Mathie R T, Ralevic V, Burnstock G
Department of Surgery, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
J Hepatol. 1996 Jul;25(1):90-7. doi: 10.1016/s0168-8278(96)80333-3.
AIMS/METHODS: The modulatory role of nitric oxide in portal vasoconstrictor responses was investigated in the isolated perfused liver of cirrhotic rats (induced by carbon tetrachloride/phenobarbitone; n = 6). Age-matched (n = 5) and phenobarbitone-treated rats (n = 5) served as controls.
At a constant flow rate of 5 ml/min there was no difference in basal perfusion pressure between the groups. Responses to electrical field stimulation of perivascular nerves caused frequency-dependent increases in perfusion pressure that were not significantly different between the groups. In contrast, dose-dependent vasoconstrictor responses to bolus injections of noradrenaline were up to two-fold greater than those observed in controls (p < 0.05). Vasoconstrictor responses to bolus injections of methoxamine (a selective alpha 1-adrenoceptor agonist) or adenosine 5'-triphosphate (ATP, a cotransmitter with noradrenaline in sympathetic nerves) were dose-dependent and similar between the groups. Infusion of the nitric oxide synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 30 microM) had no effect on basal tone or on responses to electrical field stimulation or injected agents. A step-wise increase in flow to 10, 15 and 20 ml/min produced a similar increase in perfusion pressure within each group. At increased flow, there was a decrease in responsiveness to noradrenaline (5 nmol) in preparations from all groups. In the presence of the K+ channel inhibitor glibenclamide (5 microM), the effect of noradrenaline in the cirrhotic group at flow rates of 5, 10 and 15 ml/min was maintained to a significantly greater extent than in either control group, suggesting that ATP-sensitive K+ channels in the portal venous bed may be activated in cirrhosis.
We conclude that portal vasoconstriction associated with noradrenaline, but not with sympathetic nerve stimulation, methoxamine or ATP, is enhanced in cirrhosis. Nitric oxide does not appear to play a modulatory role in these responses.
目的/方法:在四氯化碳/苯巴比妥诱导的肝硬化大鼠(n = 6)的离体灌注肝脏中研究一氧化氮在门静脉血管收缩反应中的调节作用。年龄匹配的大鼠(n = 5)和苯巴比妥处理的大鼠(n = 5)作为对照。
在5毫升/分钟的恒定流速下,各组之间的基础灌注压力没有差异。对血管周围神经进行电场刺激所引起的灌注压力随频率增加,各组之间无显著差异。相比之下,对去甲肾上腺素推注的剂量依赖性血管收缩反应比对照组高两倍(p < 0.05)。对甲氧明(一种选择性α1 -肾上腺素能受体激动剂)或5'-三磷酸腺苷(ATP,交感神经中与去甲肾上腺素共递质)推注的血管收缩反应是剂量依赖性的,且各组之间相似。一氧化氮合成抑制剂NG -硝基-L -精氨酸甲酯(L - NAME;30微摩尔)的输注对基础张力、对电场刺激或注射剂的反应均无影响。流速逐步增加至10、15和20毫升/分钟时,每组的灌注压力有类似增加。在流速增加时,所有组的制剂对去甲肾上腺素(5纳摩尔)的反应性均降低。在钾通道抑制剂格列本脲(5微摩尔)存在的情况下,肝硬化组在5、10和15毫升/分钟流速下,去甲肾上腺素的作用比任一对照组维持在显著更高的程度,提示门静脉床中的ATP敏感性钾通道在肝硬化中可能被激活。
我们得出结论,肝硬化时与去甲肾上腺素相关的门静脉血管收缩增强,但与交感神经刺激、甲氧明或ATP无关。一氧化氮似乎在这些反应中不发挥调节作用。